Literature DB >> 9654077

Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction.

K Iguchi1, M Hamatake, R Ishida, Y Usami, T Adachi, H Yamamoto, K Koshida, T Uchibayashi, K Hirano.   

Abstract

Zinc exhibits inhibitory effects on apoptosis, and a deficiency in this metal generally causes this type of cell death to occur. In the present study, we found that exposure to zinc results in necrosis of prostate carcinoma cells. When zinc acetate was added to LNCaP or PC-3 cells in monolayer culture, they began to detach from the culture dishes, and viability was lost after 4-8 h. Most of the cell death was found to be due to necrosis as determined by double staining with fluorescein-isothiocyanate-labeled annexin V and ethidium bromide, and by detection of hypodiploid cells. Associated with the induction of necrosis was an increase in low molecular-mass proteins, identified by HPLC analysis to be thymosin beta10, parathymosin and GAGE in LNCaP cells, and thymosin beta4, parathymosin and metallothionein in PC-3. The time course of the increase of thymosin beta10 in LNCaP cells and thymosin beta4 in PC-3 cells was consistent with that of appearance of cell detachment and dead cells. These results indicate that zinc can induce necrosis and suggest that production of proteins including beta-thymosins is involved in induction of processes leading to cell detachment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654077     DOI: 10.1046/j.1432-1327.1998.2530766.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Inhibitory effect of zinc on human prostatic carcinoma cell growth.

Authors:  J Y Liang; Y Y Liu; J Zou; R B Franklin; L C Costello; P Feng
Journal:  Prostate       Date:  1999-08-01       Impact factor: 4.104

2.  Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study.

Authors:  Shu-Fei Lin; Hua Wei; Dennis Maeder; Renty B Franklin; Pei Feng
Journal:  J Nutr Biochem       Date:  2008-12-13       Impact factor: 6.048

3.  Soil zinc content, groundwater usage, and prostate cancer incidence in South Carolina.

Authors:  Sara E Wagner; James B Burch; Jim Hussey; Tom Temples; Susan Bolick-Aldrich; Catishia Mosley-Broughton; Yuan Liu; James R Hebert
Journal:  Cancer Causes Control       Date:  2008-10-24       Impact factor: 2.506

4.  Direct effect of zinc on mitochondrial apoptogenesis in prostate cells.

Authors:  Pei Feng; Tie-Luo Li; Zhi-Xin Guan; Renty B Franklin; Leslie C Costello
Journal:  Prostate       Date:  2002-09-01       Impact factor: 4.104

5.  Thiophilic-interaction chromatography of enzymatically active tissue prostate-specific antigen (T-PSA) and its modulation by zinc ions.

Authors:  A K Satheesh Babu; M A Vijayalakshmi; Gary J Smith; Kailash C Chadha
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-04       Impact factor: 3.205

6.  Suppression of metallothionein 3 gene expression by androgen in LNCaP prostate cancer cells.

Authors:  Takashi Otsuka; Aki Hamada; Kazuhiro Iguchi; Shigeyuki Usui; Kazuyuki Hirano
Journal:  Biomed Rep       Date:  2013-05-17

7.  Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression.

Authors:  Liping Huang; Catherine P Kirschke; Yunfan Zhang
Journal:  Cancer Cell Int       Date:  2006-03-31       Impact factor: 5.722

8.  PIAS1-modulated Smad2/4 complex activation is involved in zinc-induced cancer cell apoptosis.

Authors:  N Yang; B Zhao; A Rasul; H Qin; J Li; X Li
Journal:  Cell Death Dis       Date:  2013-09-19       Impact factor: 8.469

9.  Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells.

Authors:  Pawatsanai Samutprasert; Khajeelak Chiablaem; Chanon Teeraseranee; Punnawich Phaiyarin; Puttikorn Pukfukdee; Prompong Pienpinijtham; Jisnuson Svasti; Tanapat Palaga; Kriengsak Lirdprapamongkol; Supason Wanichwecharungruang
Journal:  RSC Adv       Date:  2018-02-15       Impact factor: 3.361

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.